Protocol to study inflammasome activation in induced pluripotent stem cell-derived macrophages

Chloe M McKee1, Melanie Cranston1, Emma C McKay2

  • 1The Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast, Belfast, UK.

STAR Protocols
|July 28, 2026
PubMed

Insights

This study presents a new protocol for differentiating induced pluripotent stem cell-derived macrophages (iMacs) to study inflammasome activation. The protocol allows for detailed characterization and assessment of inflammasome responses in these versatile immune cells.

Area of Science:

  • Immunology
  • Stem Cell Biology
  • Molecular Biology

Background:

  • Current in vitro macrophage models present limitations for studying inflammasome activity.
  • Induced pluripotent stem cells (iPSCs) offer a promising source for generating human macrophages.

Purpose of the Study:

  • To establish and validate a protocol for differentiating iPSCs into macrophages (iMacs).
  • To characterize iMacs and demonstrate their utility in studying inflammasome activation.
  • To provide a comprehensive method for assessing inflammasome responses in iMacs.

Main Methods:

  • Differentiation of iPSCs into macrophages (iMacs).
  • Characterization of iMacs using flow cytometry, phagocytosis assays, and whole-cell proteomics.
  • Activation of various inflammasomes within iMacs.
  • Assessment of inflammasome responses via pyroptosis, cytokine release, ASC speck formation, and western blotting.

Main Results:

  • Successful differentiation and characterization of iPSCs into functional macrophages (iMacs).
  • Demonstrated ability to activate diverse inflammasomes within iMacs.
  • Quantified inflammasome responses including pyroptosis, cytokine release, and protein processing.

Conclusions:

  • iMacs provide a robust and versatile in vitro model for inflammasome research.
  • This protocol enables detailed investigation of inflammasome pathways using a renewable cell source.
  • The characterized iMacs can advance our understanding of inflammasome-mediated diseases.

Related Concept Videos